_id
69130c6fccc777a4e85d7d02
Ticker
KYTX
Name
Kyverna Therapeutics, Inc. Common Stock
Exchange
NASDAQ
Address
5980 Horton Street, Emeryville, CA, United States, 94608
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://kyvernatx.com
Description
Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome, myasthenia gravis, and lupus nephritis, as well as multiple sclerosis and systemic sclerosis. The company is also developing KYV-102, an autologous CD19 CAR T-cell product candidate with whole blood rapid manufacturing; and KYV-201, an allogeneic CD19 CAR T-cell product candidate. It has a license and collaboration agreement with Intellia Therapeutics, Inc. to research and develop an allogeneic CD19-directed CAR cell therapy product. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.
Last Close
9.5
Volume
1288072
Current Price
8.32
Change
-0.63
Last Updated
2026-01-04T16:17:51.678Z
Image
data:image/webp;base64,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
Ipo Date
2024-02-08T00:00:00.000Z
Market Cap
522749952
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9706125
Sentiment Sources
8
Rating
4.5
Target Price
29.6
Strong Buy
3
Buy
3
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
415000
Gross Profit
-415000
Operating Expenses
38312000
Operating Income
-38727000
Interest Expense
7000
Pretax Income
-36787000
Net Income
-36787000
Eps
-0.847326708075507
Dividends Per Share
-
Shares Outstanding
59606603
Income Tax Expense
-
EBITDA
-36365000
Operating Margin
-
Total Other Income Expense Net
1940000
Cash
34164000
Short Term Investments
136974000
Receivables
-
Inventories
-
Total Current Assets
174925000
Property Plant Equipment
6322000
Total Assets
187156000
Payables
3016000
Short Term Debt
3685000
Long Term Debt
-
Total Liabilities
35210000
Equity
151946000
Bs_currency_symbol
USD
Depreciation
415000
Change In Working Capital
-8853000
Cash From Operations
-43321000
Capital Expenditures
392000
Cash From Investing
22557000
Cash From Financing
1488000
Net Change In Cash
-19276000
Cf_currency_symbol
USD
PE
-
PB
2.377264642965264
ROE
-24.210574809471787
ROA
-19.65579516553036
FCF
-43713000
Fcf Percent
-
Piotroski FScore
0
Health Score
42
Deep Value Investing Score
3.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.3
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
3
Value Investing Score
4.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
415000
Quarters > 0 > income Statement > gross Profit
-415000
Quarters > 0 > income Statement > operating Expenses
38312000
Quarters > 0 > income Statement > operating Income
-38727000
Quarters > 0 > income Statement > interest Expense
7000
Quarters > 0 > income Statement > pretax Income
-36787000
Quarters > 0 > income Statement > net Income
-36787000
Quarters > 0 > income Statement > eps
-0.847326708075507
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
43415367
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-36365000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
1940000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
34164000
Quarters > 0 > balance Sheet > short Term Investments
136974000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
174925000
Quarters > 0 > balance Sheet > property Plant Equipment
6322000
Quarters > 0 > balance Sheet > total Assets
187156000
Quarters > 0 > balance Sheet > payables
3016000
Quarters > 0 > balance Sheet > short Term Debt
3685000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
35210000
Quarters > 0 > balance Sheet > equity
151946000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-36787000
Quarters > 0 > cash Flow > depreciation
415000
Quarters > 0 > cash Flow > change In Working Capital
-8853000
Quarters > 0 > cash Flow > cash From Operations
-43321000
Quarters > 0 > cash Flow > capital Expenditures
392000
Quarters > 0 > cash Flow > cash From Investing
22557000
Quarters > 0 > cash Flow > cash From Financing
1488000
Quarters > 0 > cash Flow > net Change In Cash
-19276000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.847326708075507
Quarters > 0 > ratios > PB
2.377264642965264
Quarters > 0 > ratios > ROE
-24.210574809471787
Quarters > 0 > ratios > ROA
-19.65579516553036
Quarters > 0 > ratios > FCF
-43713000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
515000
Quarters > 1 > income Statement > gross Profit
-515000
Quarters > 1 > income Statement > operating Expenses
43895000
Quarters > 1 > income Statement > operating Income
-44410000
Quarters > 1 > income Statement > interest Expense
14000
Quarters > 1 > income Statement > pretax Income
-42081000
Quarters > 1 > income Statement > net Income
-42081000
Quarters > 1 > income Statement > eps
-0.9735256139537515
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
43225365
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-41552000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
2329000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
53440000
Quarters > 1 > balance Sheet > short Term Investments
158237000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
214327000
Quarters > 1 > balance Sheet > property Plant Equipment
7577000
Quarters > 1 > balance Sheet > total Assets
226508000
Quarters > 1 > balance Sheet > payables
9917000
Quarters > 1 > balance Sheet > short Term Debt
3576000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
42131000
Quarters > 1 > balance Sheet > equity
184377000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-42081000
Quarters > 1 > cash Flow > depreciation
515000
Quarters > 1 > cash Flow > change In Working Capital
8227000
Quarters > 1 > cash Flow > cash From Operations
-31949000
Quarters > 1 > cash Flow > capital Expenditures
204000
Quarters > 1 > cash Flow > cash From Investing
29167000
Quarters > 1 > cash Flow > cash From Financing
-649000
Quarters > 1 > cash Flow > net Change In Cash
-3431000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.9735256139537515
Quarters > 1 > ratios > PB
1.950541753038611
Quarters > 1 > ratios > ROE
-22.82334564506419
Quarters > 1 > ratios > ROA
-18.57815176505907
Quarters > 1 > ratios > FCF
-32153000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
43
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
501000
Quarters > 2 > income Statement > gross Profit
-501000
Quarters > 2 > income Statement > operating Expenses
46907000
Quarters > 2 > income Statement > operating Income
-47408000
Quarters > 2 > income Statement > interest Expense
25000
Quarters > 2 > income Statement > pretax Income
-44635000
Quarters > 2 > income Statement > net Income
-44635000
Quarters > 2 > income Statement > eps
-1.0328451706198438
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
43215577
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-44109000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
2773000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
56865000
Quarters > 2 > balance Sheet > short Term Investments
185784000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
247651000
Quarters > 2 > balance Sheet > property Plant Equipment
8803000
Quarters > 2 > balance Sheet > total Assets
260655000
Quarters > 2 > balance Sheet > payables
8472000
Quarters > 2 > balance Sheet > short Term Debt
3585000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
36645000
Quarters > 2 > balance Sheet > equity
224010000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-44635000
Quarters > 2 > cash Flow > depreciation
501000
Quarters > 2 > cash Flow > change In Working Capital
-2184000
Quarters > 2 > cash Flow > cash From Operations
-44915000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
5578000
Quarters > 2 > cash Flow > cash From Financing
-414000
Quarters > 2 > cash Flow > net Change In Cash
-39751000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-1.0328451706198438
Quarters > 2 > ratios > PB
1.605078347573769
Quarters > 2 > ratios > ROE
-19.925449756707287
Quarters > 2 > ratios > ROA
-17.12416796148165
Quarters > 2 > ratios > FCF
-44915000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
2024000
Quarters > 3 > income Statement > cost Of Revenue
563000
Quarters > 3 > income Statement > gross Profit
-563000
Quarters > 3 > income Statement > operating Expenses
40478000
Quarters > 3 > income Statement > operating Income
-41041000
Quarters > 3 > income Statement > interest Expense
27000
Quarters > 3 > income Statement > pretax Income
-37489000
Quarters > 3 > income Statement > net Income
-37489000
Quarters > 3 > income Statement > eps
-0.867501356823123
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
43214918
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-36899000
Quarters > 3 > income Statement > operating Margin
-2027.7173913043478
Quarters > 3 > income Statement > total Other Income Expense Net
3552000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
96621000
Quarters > 3 > balance Sheet > short Term Investments
189358000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
290601000
Quarters > 3 > balance Sheet > property Plant Equipment
10656000
Quarters > 3 > balance Sheet > total Assets
304645000
Quarters > 3 > balance Sheet > payables
4624000
Quarters > 3 > balance Sheet > short Term Debt
3940000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
38058000
Quarters > 3 > balance Sheet > equity
266587000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-37489000
Quarters > 3 > cash Flow > depreciation
563000
Quarters > 3 > cash Flow > change In Working Capital
34000
Quarters > 3 > cash Flow > cash From Operations
-37061000
Quarters > 3 > cash Flow > capital Expenditures
532000
Quarters > 3 > cash Flow > cash From Investing
29222000
Quarters > 3 > cash Flow > cash From Financing
-215000
Quarters > 3 > cash Flow > net Change In Cash
-8042000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.867501356823123
Quarters > 3 > ratios > PB
1.3487083682250072
Quarters > 3 > ratios > ROE
-14.06257619463815
Quarters > 3 > ratios > ROA
-12.305798552413465
Quarters > 3 > ratios > FCF
-37593000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-18.573616600790515
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
2133000
Annuals > 0 > income Statement > gross Profit
-2133000
Annuals > 0 > income Statement > operating Expenses
140471000
Annuals > 0 > income Statement > operating Income
-142604000
Annuals > 0 > income Statement > interest Expense
142000
Annuals > 0 > income Statement > pretax Income
-127477000
Annuals > 0 > income Statement > net Income
-127477000
Annuals > 0 > income Statement > eps
-3.325379590135494
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
38334571
Annuals > 0 > income Statement > income Tax Expense
-127477000
Annuals > 0 > income Statement > EBITDA
-125202000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
15127000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
96621000
Annuals > 0 > balance Sheet > short Term Investments
189358000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
290601000
Annuals > 0 > balance Sheet > property Plant Equipment
10656000
Annuals > 0 > balance Sheet > total Assets
304645000
Annuals > 0 > balance Sheet > payables
4624000
Annuals > 0 > balance Sheet > short Term Debt
3940000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
38058000
Annuals > 0 > balance Sheet > equity
266587000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-127477000
Annuals > 0 > cash Flow > depreciation
2133000
Annuals > 0 > cash Flow > change In Working Capital
7857000
Annuals > 0 > cash Flow > cash From Operations
-114250000
Annuals > 0 > cash Flow > capital Expenditures
2205000
Annuals > 0 > cash Flow > cash From Investing
-160902000
Annuals > 0 > cash Flow > cash From Financing
337113000
Annuals > 0 > cash Flow > net Change In Cash
61961000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-3.325379590135494
Annuals > 0 > ratios > PB
1.261104958868962
Annuals > 0 > ratios > ROE
-47.81816067550181
Annuals > 0 > ratios > ROA
-41.84444189138177
Annuals > 0 > ratios > FCF
-116455000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
1707000
Annuals > 1 > income Statement > gross Profit
-1707000
Annuals > 1 > income Statement > operating Expenses
60699000
Annuals > 1 > income Statement > operating Income
-62406000
Annuals > 1 > income Statement > interest Expense
187000
Annuals > 1 > income Statement > pretax Income
-60366000
Annuals > 1 > income Statement > net Income
-60366000
Annuals > 1 > income Statement > eps
-0.08961405654803435
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
673622000
Annuals > 1 > income Statement > income Tax Expense
132000
Annuals > 1 > income Statement > EBITDA
-58472000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
2040000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
34647000
Annuals > 1 > balance Sheet > short Term Investments
22896000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
60664000
Annuals > 1 > balance Sheet > property Plant Equipment
10610000
Annuals > 1 > balance Sheet > total Assets
75195000
Annuals > 1 > balance Sheet > payables
4358000
Annuals > 1 > balance Sheet > short Term Debt
2920000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
26018000
Annuals > 1 > balance Sheet > equity
49177000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-60366000
Annuals > 1 > cash Flow > depreciation
1707000
Annuals > 1 > cash Flow > change In Working Capital
3424000
Annuals > 1 > cash Flow > cash From Operations
-52410000
Annuals > 1 > cash Flow > capital Expenditures
621000
Annuals > 1 > cash Flow > cash From Investing
-8785000
Annuals > 1 > cash Flow > cash From Financing
58118000
Annuals > 1 > cash Flow > net Change In Cash
-3077000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.08961405654803435
Annuals > 1 > ratios > PB
120.13064928726844
Annuals > 1 > ratios > ROE
-122.75250625292311
Annuals > 1 > ratios > ROA
-80.27927388789148
Annuals > 1 > ratios > FCF
-53031000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
22
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
7025000
Annuals > 2 > income Statement > cost Of Revenue
1051000
Annuals > 2 > income Statement > gross Profit
7025000
Annuals > 2 > income Statement > operating Expenses
36409000
Annuals > 2 > income Statement > operating Income
-29384000
Annuals > 2 > income Statement > interest Expense
65000
Annuals > 2 > income Statement > pretax Income
-28893000
Annuals > 2 > income Statement > net Income
-28893000
Annuals > 2 > income Statement > eps
-1.1197149390930956
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
25803889
Annuals > 2 > income Statement > income Tax Expense
56000
Annuals > 2 > income Statement > EBITDA
-27777000
Annuals > 2 > income Statement > operating Margin
-418.2775800711743
Annuals > 2 > income Statement > total Other Income Expense Net
491000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
37735000
Annuals > 2 > balance Sheet > short Term Investments
13587000
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
53251000
Annuals > 2 > balance Sheet > property Plant Equipment
12441000
Annuals > 2 > balance Sheet > total Assets
66924000
Annuals > 2 > balance Sheet > payables
1451000
Annuals > 2 > balance Sheet > short Term Debt
2277000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
20247000
Annuals > 2 > balance Sheet > equity
46677000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-28893000
Annuals > 2 > cash Flow > depreciation
1051000
Annuals > 2 > cash Flow > change In Working Capital
-10327000
Annuals > 2 > cash Flow > cash From Operations
-36113000
Annuals > 2 > cash Flow > capital Expenditures
768000
Annuals > 2 > cash Flow > cash From Investing
-14097000
Annuals > 2 > cash Flow > cash From Financing
11880000
Annuals > 2 > cash Flow > net Change In Cash
-38330000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-1.1197149390930956
Annuals > 2 > ratios > PB
4.848214463868715
Annuals > 2 > ratios > ROE
-61.899865029886236
Annuals > 2 > ratios > ROA
-43.17285278823741
Annuals > 2 > ratios > FCF
-36881000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-5.249964412811388
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
5656000
Annuals > 3 > income Statement > cost Of Revenue
586000
Annuals > 3 > income Statement > gross Profit
5656000
Annuals > 3 > income Statement > operating Expenses
32002000
Annuals > 3 > income Statement > operating Income
-26346000
Annuals > 3 > income Statement > interest Expense
3000
Annuals > 3 > income Statement > pretax Income
-26350000
Annuals > 3 > income Statement > net Income
-26350000
Annuals > 3 > income Statement > eps
-1.021163902852008
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
25803889
Annuals > 3 > income Statement > income Tax Expense
1000
Annuals > 3 > income Statement > EBITDA
-25761000
Annuals > 3 > income Statement > operating Margin
-465.8062234794908
Annuals > 3 > income Statement > total Other Income Expense Net
-4000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
76067000
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
77087000
Annuals > 3 > balance Sheet > property Plant Equipment
7808000
Annuals > 3 > balance Sheet > total Assets
85488000
Annuals > 3 > balance Sheet > payables
773000
Annuals > 3 > balance Sheet > short Term Debt
814000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
131742000
Annuals > 3 > balance Sheet > equity
-46254000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-26350000
Annuals > 3 > cash Flow > depreciation
586000
Annuals > 3 > cash Flow > change In Working Capital
-4491000
Annuals > 3 > cash Flow > cash From Operations
-22155000
Annuals > 3 > cash Flow > capital Expenditures
1289000
Annuals > 3 > cash Flow > cash From Investing
-1289000
Annuals > 3 > cash Flow > cash From Financing
72523000
Annuals > 3 > cash Flow > net Change In Cash
49079000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-1.021163902852008
Annuals > 3 > ratios > PB
-4.892552136680071
Annuals > 3 > ratios > ROE
56.96804600683184
Annuals > 3 > ratios > ROA
-30.823039490922703
Annuals > 3 > ratios > FCF
-23444000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-4.144978783592645
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.847326708075507
Valuation > metrics > PB
2.377264642965264
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-24.210574809471787
Profitability > metrics > ROA
-21.03015578104902
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.23172706092954076
Risk > metrics > Interest Coverage
-5532.428571428572
Risk > final Score
-22070
Risk > verdict
High
Liquidity > metrics > Current Ratio
26.10431278913595
Liquidity > metrics > Quick Ratio
26.10431278913595
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-12629
Prev Risks > 1
-7525
Prev Risks > 2
-6020
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:07:12.080Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-13
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.85
Earnings History > 0 > eps Estimate
-1.02
Earnings History > 0 > eps Difference
0.17
Earnings History > 0 > surprise Percent
16.6667
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-12
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.97
Earnings History > 1 > eps Estimate
-1.02
Earnings History > 1 > eps Difference
0.05
Earnings History > 1 > surprise Percent
4.902
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-14
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-1.03
Earnings History > 2 > eps Estimate
-1.0027
Earnings History > 2 > eps Difference
-0.0273
Earnings History > 2 > surprise Percent
-2.7226
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-27
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.8678
Earnings History > 3 > eps Estimate
-0.95
Earnings History > 3 > eps Difference
0.0822
Earnings History > 3 > surprise Percent
8.6526
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-13
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.8
Earnings History > 4 > eps Estimate
-0.84
Earnings History > 4 > eps Difference
0.04
Earnings History > 4 > surprise Percent
4.7619
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-12
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.67
Earnings History > 5 > eps Estimate
-0.78
Earnings History > 5 > eps Difference
0.11
Earnings History > 5 > surprise Percent
14.1026
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-14
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-1.12
Earnings History > 6 > eps Estimate
-0.84
Earnings History > 6 > eps Difference
-0.28
Earnings History > 6 > surprise Percent
-33.3333
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-26
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-26.86
Earnings History > 7 > eps Estimate
-3.23
Earnings History > 7 > eps Difference
-23.63
Earnings History > 7 > surprise Percent
-731.5789
Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome, myasthenia gravis, and lupus nephritis, as well as multiple sclerosis and systemic sclerosis. The company is also developing KYV-102, an autologous CD19 CAR T-cell product candidate with whole blood rapid manufacturing; and KYV-201, an allogeneic CD19 CAR T-cell product candidate. It has a license and collaboration agreement with Intellia Therapeutics, Inc. to research and develop an allogeneic CD19-directed CAR cell therapy product. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AFed Meeting: Will KYTX outperform the market in YEAR - Trade Volume Summary & Safe Capital Growth Stock Tips baoquankhu1.vn
Read more →Profit Recap: Is Avnet Incs ROIC above industry average - July 2025 Intraday Action & Expert Approved Momentum Ideas baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$29.6
Analyst Picks
Strong Buy
3
Buy
3
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Kyverna Therapeutics, Inc. Common Stock
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.85
EPS Estimate
-1.02
EPS Difference
0.17
Surprise Percent
16.6667%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.